Hillenbrand (HI) 10-Q 5 Feb 25 2025 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Dec. 31, 2024	Jan. 31, 2025
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2024
Document Transition Report	false
Entity File Number	001-33794
Entity Registrant Name	HILLENBRAND, INC.
Entity Incorporation, State or Country Code	IN
Entity Tax Identification Number	26-1342272
Entity Address, Address Line One	One Batesville Boulevard
Entity Address, City or Town	Batesville,
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	47006
City Area Code	812
Local Phone Number	931-5000
Title of 12(b) Security	Common Stock, without par value
Trading Symbol	HI
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		70,420,357
Entity Central Index Key	0001417398
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q1
Amendment Flag	false

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Net revenue	$ 706.9	$ 773.3
Cost of goods sold	471.9	522.3
Gross profit	235	251
Operating expenses	171.1	157.9
Amortization expense	25.2	25.5
Pension settlement (gain) charge	(1.7)	8.3
Interest expense, net	25.1	29.8
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	15.3	29.5
Income tax expense	6.4	10
Income from continuing operations	8.9	19.5
Loss from discontinued operations (net of income tax expense)	0	(0.3)
Consolidated net income	8.9	19.2
Less: Net income attributable to noncontrolling interests	2.5	2
Net income attributable to Hillenbrand	$ 6.4	$ 17.2
Basic earnings per share
Income from continuing operations attributable to Hillenbrand (in dollars per share)	$ 0.09	$ 0.25
Income from discontinued operations (in dollars per share)	0	0
Net income attributable to Hillenbrand	0.09	0.25
Diluted earnings per share
Income from continuing operations attributable to Hillenbrand (in dollars per share)	0.09	0.25
Income from discontinued operations (in dollars per share)	0	(0.01)
Diluted earnings per share	$ 0.09	$ 0.24
Weighted average shares outstanding (basic)	70.6	70.3
Weighted average shares outstanding (diluted)	70.6	70.5

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Statement of Comprehensive Income [Abstract]
Consolidated net income (loss)	$ 8.9	$ 19.2
Changes in other comprehensive (loss) income, net of tax:
Currency translation adjustment (1)	(63.9)	49.3
Pension and postretirement	0.8	6
Change in net unrealized gain on derivative instruments	27.9	0.9
Total changes in other comprehensive (loss) income, net of tax	(35.2)	56.2
Consolidated comprehensive (loss) income	(26.3)	75.4
Less: Comprehensive income attributable to noncontrolling interests	1.9	2
Comprehensive income (loss)	$ (28.2)	$ 73.4

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Current Assets
Cash and cash equivalents	$ 208	$ 199.3
Trade receivables, net	309.5	350.1
Receivables from long-term manufacturing contracts, net	289.5	302.7
Inventories, net	521.7	525.2
Prepaid expenses and other current assets	134	132.6
Total current assets	1,462.7	1,509.9
Property, plant, and equipment, net	303.7	316.6
Operating lease right-of-use assets, net	157.8	168.7
Intangible assets, net	1,229.4	1,285.9
Goodwill	1,779.1	1,835.7
Other long-term assets	126.7	121.9
Total Assets	5,059.4	5,238.7
Current Liabilities
Trade accounts payable	405.3	444.8
Liabilities from long-term manufacturing contracts and advances	293.8	315.2
Current portion of long-term debt	20.9	20.6
Accrued compensation	93.1	122
Other current liabilities	276.6	286.5
Total current liabilities	1,089.7	1,189.1
Long-term debt	1,885	1,872.4
Accrued pension and postretirement healthcare	102	109.3
Operating lease liabilities	131.8	141.1
Deferred income taxes	295.5	314.3
Other long-term liabilities	139	155.1
Total Liabilities	3,643	3,781.3
Commitments and contingencies (Note 13)
SHAREHOLDERS’ EQUITY
Common stock, no par value (75.8 and 75.8 shares issued, 70.4 and 70.2 shares outstanding)	0	0
Additional paid-in capital	707.6	712.6
Retained earnings	1,035.5	1,045.2
Treasury stock (5400000 and 5600000 shares, at cost)	(230.6)	(238.2)
Accumulated other comprehensive loss	(131.2)	(96.6)
Hillenbrand Shareholders’ Equity	1,381.3	1,423
Noncontrolling interests	35.1	34.4
Total Shareholders’ Equity	1,416.4	1,457.4
Total Liabilities and Shareholders’ Equity	$ 5,059.4	$ 5,238.7

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - shares shares in Millions	Dec. 31, 2024	Sep. 30, 2024
Statement of Financial Position [Abstract]
Common stock, shares issued	75.8	75.8
Common stock, shares outstanding	70.4	70.2
Treasury stock (in shares)	5.4	5.6

Consolidated Statements of Cash

Consolidated Statements of Cash Flow - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating activities from continuing operations
Consolidated net income	$ 8.9	$ 19.2
Adjustments to reconcile income from continuing operations to cash provided by operating activities:
Loss from discontinued operations (net of income tax expense)	0	0.3
Depreciation and amortization	37.9	38.8
Deferred income taxes	(4.8)	(22.4)
Amortization of deferred financing costs	1.2	1.1
Share-based compensation	4.7	5.2
Trade accounts receivable, net and receivables from long-term manufacturing contracts	17.2	36.7
Inventories, net	(13.3)	(1.7)
Prepaid expenses and other current assets	(3.6)	(22)
Trade accounts payable	(23.8)	(38.9)
accrued compensation, and other current liabilities	(25.8)	(57.7)
Income taxes payable	(8.9)	14.9
Accrued pension and postretirement	(0.5)	6.5
Other, net	(0.5)	(4)
Net cash used in operating activities from continuing operations	(11.3)	(24)
Investing activities from continuing operations
Capital expenditures	(10.2)	(12.4)
Proceeds from sales of property, plant, and equipment	0.5	0.1
Proceeds From Cross-Currency Swap Settlement	9.1	0
Collection of deferred purchase price receivables	10.1	0
Other, net	0	2.8
Net cash provided by (used in) investing activities from continuing operations	9.5	(15.1)
Financing activities from continuing operations
Repayments on long-term debt	(4.9)	(2.5)
Proceeds from revolving credit facilities	119.6	31.4
Repayments on revolving credit facilities	(68.2)	(24.2)
Payments of dividends on common stock	(15.8)	(15.6)
Proceeds from stock option exercises	0.8	0.6
Payments for employee taxes on net settlement equity awards	(3.2)	(5.3)
Other, net	(1.5)	(1.5)
Net cash provided by (used in) financing activities from continuing operations	26.8	(17.1)
Cash provided by (used in) continuing operations	25	(56.2)
Cash used in discontinued operations:
Operating cash flows	0	0
Investing cash flows	0	0
Total cash used in discontinued operations	0	0
Effect of exchange rates on cash and cash equivalents	(14.4)	5.6
Net cash flows	10.6	(50.6)
Cash, cash equivalents, and restricted cash:
At beginning of period	227.9	250.2
At end of period	$ 238.5	$ 199.6

Consolidated Statements of Shar

Consolidated Statements of Shareholders Equity Statement - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Loss	Noncontrolling Interests
Balance, shares at Sep. 30, 2023		75.8			5.9
Balance at Sep. 30, 2023	$ 1,662.9		$ 709.5	$ 1,319.6	$ (251.7)	$ (147.1)	$ 32.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total other comprehensive income (loss), net of tax	56.2					56.2	0
Income from continuing operations	19.2			17.2			2
Common stock, shares issued					(0.2)
Issuance/retirement of stock for stock awards/options	(4.7)		(13.7)		$ 9
Share-based compensation	5.2		5.2
Dividends, Common Stock	(16.8)		0.2	(15.8)			(1.2)
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	(3)						(3)
Balance at Dec. 31, 2023	1,719		701.2	1,321	$ (242.7)	(90.9)	30.4
Balance, shares at Dec. 31, 2023		75.8			5.7
Balance, shares at Sep. 30, 2024		75.8			5.6
Balance at Sep. 30, 2024	1,457.4		712.6	1,045.2	$ (238.2)	(96.6)	34.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Total other comprehensive income (loss), net of tax	(35.2)					(34.6)	(0.6)
Income from continuing operations	8.9			6.4			2.5
Common stock, shares issued					(0.2)
Issuance/retirement of stock for stock awards/options	(2.4)		(10)		$ 7.6
Share-based compensation	4.7		4.7
Dividends, Common Stock	(17)		0.3	(16.1)			(1.2)
Balance at Dec. 31, 2024	$ 1,416.4		$ 707.6	$ 1,035.5	$ (230.6)	$ (131.2)	$ 35.1
Balance, shares at Dec. 31, 2024		75.8			5.4

Statement of Shareholders' Equi

Statement of Shareholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Statement of Stockholders' Equity [Abstract]
Common Stock, Dividends, Per Share, Cash Paid	$ 0.225	$ 0.2225

Background and Basis of Present

Background and Basis of Presentation	3 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation Hillenbrand, Inc. (the “Company” or “Hillenbrand”) is a global industrial company that provides highly-engineered processing equipment and solutions to customers around the world. Our portfolio is composed of leading industrial brands that serve large, attractive end markets, including durable plastics, food, and recycling. Guided by our Purpose, Shape What Matters for Tomorrow TM , we pursue excellence, collaboration, and innovation to shape solutions that best serve our people, our customers, and our communities. Customers choose Hillenbrand due to our reputation for designing, manufacturing, and servicing highly-engineered, mission-critical equipment and solutions that meet their unique and complex processing requirements. On February 1, 2023, the Company completed the divestiture of its historical Batesville reportable operating segment (“Batesville”) to BL Memorial Partners, LLC, a Delaware limited liability company owned by funds affiliated with LongRange Capital, L.P., for $761.5, including an $11.5 subordinated note. This divestiture represented a strategic shift in Hillenbrand’s business and qualified as a discontinued operation. Accordingly, the operating results and cash flows related to Batesville have been reflected as discontinued operations in the Consolidated Statements of Operations and the Consolidated Statements of Cash Flows for all periods presented. Unless otherwise noted, discussion within the condensed notes to the Consolidated Financial Statements relates to continuing operations only and excludes Batesville. Hillenbrand is composed of two reportable operating segments: Advanced Process Solutions and Molding Technology Solutions. Advanced Process Solutions is a leading global provider of highly-engineered process and material handling equipment, systems, and aftermarket parts and services for a variety of industries, including durable plastics, food, and recycling. Molding Technology Solutions is a global leader in highly-engineered equipment, systems, and aftermarket parts and service for the plastic technology processing industry. Molding Technology Solutions has a comprehensive product portfolio that includes injection molding and extrusion equipment, hot runner systems, process control systems, mold bases and components, and maintenance, repair, and operating (“MRO”) supplies. The Consolidated Financial Statements include the accounts of Hillenbrand and its subsidiaries. They also include three subsidiaries where the Company’s ownership percentage is less than 100%. The Company’s fiscal year ends on September 30. Unless otherwise stated, references to years refer to fiscal years. These unaudited Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements and therefore do not include all information required in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”). The unaudited Consolidated Financial Statements have been prepared on the same basis as, and should be read in conjunction with, the audited Consolidated Financial Statements and notes thereto included in the Company’s latest Annual Report on Form 10-K for the year ended September 30, 2024, as filed with the SEC on November 19, 2024. In the opinion of management, these unaudited Consolidated Financial Statements reflect all adjustments necessary to present a fair statement of the Company’s consolidated financial position and the consolidated results of operations and cash flows as of the dates and for the periods presented and are normal and recurring in nature. The interim period results are subject to variation and are not necessarily indicative of the consolidated results of operations to be expected for the full fiscal year. The preparation of the Consolidated Financial Statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of net revenue and expenses during the period. Actual results could differ from those estimates. Examples of such estimates include, but are not limited to, revenue recognition under the over time method, establishment of reserves related to credit losses, warranties, income taxes, litigation, and self-insurance.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies The significant accounting policies used in preparing the Consolidated Financial Statements are consistent with the accounting policies described in the Company’s Annual Report on Form 10-K as of and for the year ended September 30, 2024. Recently issued accounting standards In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . ASU 2023-07 requires additional disclosures pertaining to significant expenses and other items of an entity’s reportable operating segments. ASU 2023-07 is effective for annual periods beginning after December 15, 2023 (fiscal 2025), and interim periods beginning in fiscal 2026. The Company is currently evaluating the impact of ASU 2023-07 on the Consolidated Financial Statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. ASU 2023-09 will be effective for annual periods beginning after December 15, 2024 (fiscal 2026). The Company is currently evaluating the impact of ASU 2023-09 on the Consolidated Financial Statements. In March 2024, the SEC adopted final rules requiring public entities to provide certain climate-related information in their registration statements and annual reports. As part of the disclosures, entities will be required to quantify certain effects of severe weather events and other natural conditions in a note to their audited financial statements. The rules will be effective for annual periods beginning in calendar 2025 (fiscal 2026). In April 2024, the SEC voluntarily stayed implementation of the final rules pending certain legal challenges. The Company is assessing the effect of the new rules on our Consolidated Financial Statements and related disclosures. In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (ASU 2024-03), which requires, among other items, additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included on the face of the Consolidated Statement of Operations. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 (fiscal 2028), and for interim periods within fiscal years beginning after December 15, 2027 (fiscal 2029), with early adoption permitted. The Company is currently evaluating the impact of ASU 2024-03 on the Consolidated Financial Statements. No other new accounting pronouncements recently adopted or issued had or are expected to have a material impact on the Consolidated Financial Statements.

Revenue Recognition

Revenue Recognition	3 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Net revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services and is recognized when performance obligations are satisfied under the terms of contracts with customers. Contract balances The balance in receivables from long-term manufacturing contracts at December 31, 2024 and September 30, 2024, was $289.5 and $302.7, respectively. The change was driven by the impact of net revenue recognized prior to billings to customers. The balance in the liabilities from long-term manufacturing contracts and advances at December 31, 2024 and September 30, 2024, was $293.8 and $315.2, respectively, and consists primarily of cash payments received or due in advance of satisfying performance obligations. The net revenue recognized for the three months ended December 31, 2024 and 2023, related to liabilities from long-term manufacturing contracts and advances as of September 30, 2024 and 2023, was $95.6 and $116.4, respectively. During the three months ended December 31, 2024 and 2023, the adjustments related to performance obligations satisfied in previous periods were immaterial. Transaction price allocated to the remaining performance obligations As of December 31, 2024, the aggregate amount of transaction price of remaining performance obligations for the Company, which corresponds to backlog as defined in Part I, Item 2 of this Quarterly Report on Form 10-Q, was $1,816.7. Approximately 88% of these performance obligations are expected to be satisfied over the next twelve months, and the remaining performance obligations, primarily within one to three years. Disaggregation of revenue The following tables present net revenue by geography: Three Months Ended December 31, 2024 Three Months Ended December 31, 2023 Advanced Process Solutions Molding Technology Solutions Total Advanced Process Solutions Molding Technology Solutions Total Geography (1) Americas $ 229.2 $ 102.9 $ 332.1 $ 264.2 $ 109.9 $ 374.1 Asia 128.8 60.2 189.0 146.3 60.5 206.8 Europe, the Middle East, and Africa 153.1 32.7 185.8 157.8 34.6 192.4 Total $ 511.1 $ 195.8 $ 706.9 $ 568.3 $ 205.0 $ 773.3 (1) The Company attributes net revenue to a geography based upon the location of the end customer. The following tables present net revenue by timing of transfer: Three Months Ended December 31, 2024 Three Months Ended December 31, 2023 Advanced Process Solutions Molding Technology Solutions Total Advanced Process Solutions Molding Technology Solutions Total Timing of transfer Point in time $ 269.8 $ 181.1 $ 450.9 $ 278.2 $ 186.4 $ 464.6 Over time 241.3 14.7 256.0 290.1 18.6 308.7 Total $ 511.1 $ 195.8 $ 706.9 $ 568.3 $ 205.0 $ 773.3

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	3 Months Ended
	Dec. 31, 2024
Balance Sheet Related Disclosures [Abstract]
Supplemental Balance Sheet Information	Supplemental Consolidated Balance Sheet Information December 31, 2024 September 30, 2024 Allowance for credit losses $ 13.7 $ 13.6 Warranty reserves $ 46.7 $ 47.9 Accumulated depreciation on property, plant, and equipment $ 268.7 $ 265.6 Inventories, net: Raw materials and components $ 248.1 $ 247.0 Work in process 120.1 127.6 Finished goods 153.5 150.6 Total inventories, net $ 521.7 $ 525.2 The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the Consolidated Balance Sheets that sum to the total of the same amounts shown in the Consolidated Statements of Cash Flows: December 31, 2024 December 31, 2023 Cash and cash equivalents $ 208.0 $ 198.4 Short-term restricted cash included in other current assets 6.9 1.2 Long-term restricted cash included in other long-term assets 23.6 — Total cash and cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows $ 238.5 $ 199.6 Equity Method Investment The Consolidated Financial Statements include our 46% interest in TerraSource Holdings, LLC (“Holdings”), which is accounted for using the equity method of accounting as we have significant influence over the operating and financial policies of Holdings; however, we do not control Holdings. When we record our proportionate share of net income, we record it as a reduction to Operating expenses in the Consolidated Statements of Operations and increase the carrying value of our equity method investment. Conversely, when we record our proportionate share of a net loss, if applicable, we record it within Operating expenses in the Consolidated Statements of Operations and decrease the carrying value of our equity method investment. The value of our equity method investment in Holdings, which is recorded in Other long-term assets, was $12.0 and $9.2 at December 31, 2024 and September 30, 2024, respectively. We recorded our proportionate share of net income of Holdings of $2.8 and $1.5 for the three months ended December 31, 2024 and 2023, respectively, as a reduction of Operating expenses. Supplier Finance Program The Company has an agreement with a third-party to facilitate a supply chain finance (“SCF”) program with participating financial institutions. The SCF program allows qualifying suppliers to sell their receivables, on an invoice level at the selection of the supplier, from the Company to the financial institutions and negotiate their outstanding receivable arrangements and associated fees directly with the financial institutions. Hillenbrand is not party to the agreements between the supplier and the financial institutions. The supplier invoices that have been confirmed as valid under the SCF program require payment in full by the financial institutions to the supplier by the original maturity date of the invoice, or discounted payment at an earlier date as agreed upon with the supplier. The Company’s obligations to its suppliers, including amounts due and scheduled payment terms, are not impacted by a supplier’s participation in the SCF program. All outstanding amounts related to suppliers participating in the SCF program are recorded upon confirmation with the third-party financial institutions in trade accounts payable in the Consolidated Balance Sheets, and associated payments are included in cash used in operating activities in the Consolidated Statements of Cash Flows. The Company’s outstanding obligations included in trade accounts payable as of December 31, 2024 and September 30, 2024, were $14.4 and $16.0, respectively. Trade Receivables Financing Agreements The Company sells a small percentage of its trade receivables to outside financial institutions in the normal course of business. These trade receivable financing agreements are accounted for as a true sale of assets under the provisions of Accounting Standards Codification (“ASC”) 860, Transfer and Servicing (“ASC 860”). During fiscal 2024, the Company executed an amendment of one of its trade receivables financing agreement (as amended, the “Amended Agreement”) with a financial institution. In accordance with ASC 860 this Amended Agreement is deemed a true sale, as the Company retains no rights or interest and has no obligations with respect to the trade receivables, and has no continuing involvement with the trade receivables once transferred to the financial institution. As part of the Amended Agreement, we receive the majority of the proceeds of the trade receivables sold to the financial institution upon sale in cash (level 1 fair value measurement) with the remaining portion of the proceeds held by the financial institution as a deferred purchase price (“DPP”) (level 2 fair value measurement) until the collection of the trade receivables sold. The DPP receivables are ultimately realized by the Company following the collection of the underlying trade receivables sold to the financial institution (typically within 90 - 120 days). As defined in the Amended Agreement, the financial institution is responsible for any credit risk associated with the sold trade receivables. There is no limit on the amount of trade receivables that can be sold under the Amended Agreement; however, all trade receivables must be accepted by the financial institution prior to sale. Sales of trade receivables under the Amended Agreement and other trade receivable factoring arrangements were $70.8 and $7.2 for the three months ended December 31, 2024 and 2023, respectively, and cash collections from customers on trade receivables sold were $71.7 and $7.2 during the three months ended December 31, 2024 and 2023, respectively. The Company acts as a servicer (collects customer cash on behalf of the financial institution) for one of its trade receivables factoring arrangements. The servicing fee associated with this trade receivables factoring arrangement was not material to the Company for the three months ended December 31, 2024 and 2023, respectively. Amounts collected on behalf of the financial institution under this trade receivables factoring arrangement and owed to the financial institution were $2.2 and $3.1 at December 31, 2024 and September 30, 2024, respectively. The loss on the sale of trade receivables under the Amended Agreement and other trade receivables factoring arrangements was not material to the Company for the three months ended December 31, 2024 and 2023. As of December 31, 2024 and September 30, 2024, trade receivables in the amount of $28.5 and $34.2, respectively were sold to the financial institution and are not reflected in trade receivables in the Consolidated Balance Sheets. The following roll forward summarizes the activity related to the DPP receivables: Three Months Ended December 31, 2024 Three Months Ended December 31, 2023 Beginning DPP receivables balance $ 6.7 $ — Non-cash additions to DPP receivables 9.2 — Cash collections on DPP receivables (10.1) — Ending DPP receivables balance $ 5.8 $ —

Leases

Leases	3 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Leases	Leases For the three months ended December 31, 2024 and 2023, the Company recognized $10.5 and $8.5 of operating lease expense, respectively, including short-term lease expense and variable lease costs, which were immaterial in each period. The Company’s finance leases were insignificant as of December 31, 2024 and September 30, 2024. The following table presents supplemental Consolidated Balance Sheet information related to the Company’s operating leases: December 31, 2024 September 30, 2024 Operating lease right-of-use assets, net $ 157.8 $ 168.7 Other current liabilities 20.5 22.0 Operating lease liabilities 131.8 141.1 Total operating lease liabilities $ 152.3 $ 163.1 Weighted-average remaining lease term (in years) 10.1 10.3 Weighted-average discount rate 6.3 % 6.3 % As of December 31, 2024, the maturities of the Company’s operating lease liabilities were as follows: 2025 (excluding the three months ended December 31, 2024) $ 21.4 2026 25.9 2027 23.0 2028 20.8 2029 19.2 Thereafter 111.4 Total lease payments 221.7 Less: imputed interest (69.4) Total present value of lease payments $ 152.3 Supplemental Consolidated Statements of Cash Flow information related to the Company’s operating leases is as follows: Three Months Ended December 31, 2024 2023 Cash paid for amounts included in the measurement of operating lease liabilities $ 8.0 $ 6.8 Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities 4.6 4.9 Operating leases acquired in business combinations — 3.5

Intangible Assets and Goodwill

Intangible Assets and Goodwill	3 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	Intangible Assets and Goodwill Intangible Assets Intangible assets are stated at the lower of cost or fair value. Intangible assets are amortized on a straight-line basis over periods ranging from three The following table summarizes the carrying amounts and related accumulated amortization for intangible assets as of: December 31, 2024 September 30, 2024 Cost Accumulated Cost Accumulated Finite-lived assets: Customer relationships $ 1,278.6 $ (386.8) $ 1,316.9 $ (379.4) Technology, including patents 189.3 (101.8) 192.3 (100.9) Software 56.4 (38.9) 53.0 (35.3) Trade names 50.2 (11.5) 52.5 (10.6) 1,574.5 (539.0) 1,614.7 (526.2) Indefinite-lived assets: Trade names 193.9 — 197.4 — Total $ 1,768.4 $ (539.0) $ 1,812.1 $ (526.2) Finite-lived intangible assets, net of $658.6 and $693.0 are included in the Advanced Process Solutions reportable operating segment at December 31, 2024 and September 30, 2024, respectively. Indefinite-lived intangible assets of $108.8 and $112.3 are included in the Advanced Process Solutions reportable operating segment at December 31, 2024 and September 30, 2024, respectively. The net change in intangible assets in the Advanced Process Solutions reportable operating segment during the three months ended December 31, 2024, was driven primarily by amortization and foreign currency adjustments. Finite-lived intangible assets, net of $369.7 and $388.3 are included in the Molding Technology Solutions reportable operating segment at December 31, 2024 and September 30, 2024, respectively. Indefinite-lived intangible assets of $85.1 are included in the Molding Technology Solutions reportable operating segment at both December 31, 2024 and September 30, 2024. The net change in intangible assets in the Molding Technology Solutions reportable operating segment during the three months ended December 31, 2024, was driven primarily by amortization and foreign currency adjustments. Goodwill Goodwill is not amortized, but is subject to annual impairment tests. Goodwill has been assigned to reporting units within the reportable operating segments. The Company assesses the carrying value of goodwill annually, or more often if events or changes in circumstances indicate there may be impairment. Impairment testing is performed at a reporting unit level. The following table summarizes the changes in the Company’s goodwill, by reportable operating segment, for the three months ended December 31, 2024: Advanced Process Solutions Molding Technology Solutions Total Balance as of September 30, 2024 $ 1,430.2 $ 405.5 $ 1,835.7 Foreign currency adjustments (48.7) (7.9) (56.6) Balance as of December 31, 2024 $ 1,381.5 $ 397.6 $ 1,779.1 During the three months ended December 31, 2024 and 2023, the Company did not observe any triggering events or substantive changes in circumstances requiring the need for an interim impairment assessment.

Financing Agreements

Financing Agreements	3 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Financing Agreements	Financing Agreements The following table summarizes Hillenbrand’s current and long-term debt as of: December 31, 2024 September 30, 2024 $1,000 revolving credit facility (excluding outstanding letters of credit) $ 329.0 $ 298.5 $200 term loan 180.0 182.5 €185 term loan 180.9 196.5 $500 senior unsecured notes (1) 495.0 494.6 $375 senior unsecured notes (2) 373.8 373.6 $350 senior unsecured notes (3) 347.2 347.1 Other — 0.2 Total debt 1,905.9 1,893.0 Less: current portion 20.9 20.6 Total long-term debt $ 1,885.0 $ 1,872.4 (1) Includes unamortized debt issuance costs of $5.0 and $5.4 at December 31, 2024 and September 30, 2024, respectively. (2) Includes unamortized debt issuance costs of $1.0 and $1.2 at December 31, 2024 and September 30, 2024, respectively. (3) Includes unamortized debt issuance costs of $2.8 and $2.9 at December 31, 2024 and September 30, 2024, respectively. As of December 31, 2024, the Company had $17.7 in outstanding letters of credit issued and $653.3 of borrowing capacity under the revolving credit facility (the “Facility”), of which $424.3 was immediately available based on the Company’s most restrictive covenant. The weighted-average interest rate on borrowings under the Facility was 4.96% and 5.84% for the three months ended December 31, 2024 and 2023, respectively. The weighted average facility fee on the Facility was 0.24% and 0.20% for the three months ended December 31, 2024 and 2023, respectively. The weighted-average interest rate on the $200 term loan was 6.69% and 5.60% for the three months ended December 31, 2024 and 2023, respectively. The weighted-average interest rate on the €185 term loan was 5.05% and 5.60% for the three months ended December 31, 2024 and 2023, respectively. Remaining unamortized deferred financing costs related to the Facility, $200 term loan and €185 term loan were $5.0 in aggregate, as of December 31, 2024, and are being amortized to interest expense over the remaining term of these agreements. In the normal course of business, the Company provides, primarily to certain customers, bank guarantees and other credit arrangements in support of performance, warranty, advance payment, and other contractual obligations. This form of trade finance is customary in the industry and, as a result, the Company maintains adequate capacity to provide the guarantees. As of December 31, 2024 and September 30, 2024, the Company had credit arrangements totaling $561.3 and $594.3, respectively, under which $331.7 and $400.2, respectively, were used for guarantees. These arrangements include the Company’s Syndicated L/G Facility Agreement (“L/G Facility”) and other ancillary credit facilities. Remaining unamortized deferred financing costs related to the L/G Facility were $1.4 as of December 31, 2024, and are being amortized to interest expense over the remaining term of the agreement. As of December 31, 2024, Hillenbrand was in compliance with all covenants contained in the foregoing agreements and credit instruments and there were no events of default.

Retirement Benefits

Retirement Benefits	3 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Retirement Benefits	Retirement Benefits Defined Benefit Plans Components of net periodic pension (benefit) cost included in the Consolidated Statements of Operations were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits Three Months Ended December 31, Three Months Ended December 31, 2024 2023 2024 2023 Service costs $ — $ — $ 0.7 $ 0.5 Interest costs 0.2 2.0 0.8 1.1 Expected return on plan assets — (2.7) (0.3) (0.4) Amortization of net loss (gain) — 0.1 (0.2) (0.2) Settlement (gain) charge (1.7) 8.3 — — Net periodic pension (benefit) cost $ (1.5) $ 7.7 $ 1.0 $ 1.0 On July 18, 2023, we announced an offer to provide former employees who are participants in the Company’s U.S. defined benefit pension plan (the “Plan”) the opportunity to elect a lump sum distribution of their earned Plan benefits. The Plan’s fiduciaries made lump sum payments to electing eligible participants in December 2023, funded by the existing assets in the Plan. In April 2024, the remaining assets of the Plan were used to purchase annuities to support the remaining obligation, resulting in the termination and liquidation of the Plan. During the three months ended December 31, 2024, the Company received one-time premium refunds of $1.7 related to the termination of the Plan, which was recorded as a pretax pension settlement gain on the Consolidated Statement of Operations. During the three months ended December 31, 2023, the Company recorded a non-cash settlement pre-tax charge of $8.3, related to the termination and liquidation of the Plan. Defined Contribution Plans

Income Taxes

Income Taxes	3 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The effective tax rates for the three months ended December 31, 2024 and 2023 were 41.8% and 33.9%, respectively. The increase in the effective tax rate was primarily driven by an increase in unrecognized tax benefits, the expiration of a reduced incentive tax rate for certain operations located in China, and a reduced discrete tax benefit for equity compensation, partially offset by the revaluation of Canadian deferred tax liabilities as a result of currency fluctuation, and a reduction of the tax accrual for unrepatriated earnings.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings per share The dilutive effects of performance-based stock awards were included in the computation of diluted earnings per share at the level the related performance criteria were met through the respective Consolidated Balance Sheet date. Potential dilutive effects, representing approximately 630,000 and 440,000 shares at December 31, 2024 and 2023, respectively, were excluded from the computation of diluted earnings per share as the related performance criteria were not yet met, although the Company expects to meet various levels of criteria in the future. Three Months Ended 2024 2023 Income from continuing operations $ 8.9 $ 19.5 Less: Net income attributable to noncontrolling interests 2.5 2.0 Income from continuing operations attributable to Hillenbrand $ 6.4 $ 17.5 Weighted-average shares outstanding (basic - in millions) 70.6 70.3 Effect of dilutive stock options and other unvested equity awards (in millions) — 0.2 Weighted-average shares outstanding (diluted - in millions) 70.6 70.5 Basic earnings per share from continuing operations attributable to Hillenbrand $ 0.09 $ 0.25 Diluted earnings per share from continuing operations attributable to Hillenbrand $ 0.09 $ 0.25 Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions) 0.9 0.6

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
	Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss The following tables summarize the changes in the accumulated balances for each component of accumulated other comprehensive loss: Pension and Currency Translation (1) Net Total Noncontrolling Total Balance at September 30, 2024 $ (15.6) $ (55.4) $ (25.6) $ (96.6) Other comprehensive loss before reclassifications: Before tax amount 1.1 (63.3) 26.5 (35.7) $ (0.6) $ (36.3) Tax benefit (0.3) — 0.7 0.4 — 0.4 After tax amount 0.8 (63.3) 27.2 (35.3) (0.6) (35.9) Amounts reclassified from accumulated other comprehensive loss (2) — — 0.7 0.7 — 0.7 Net current period other comprehensive income (loss) 0.8 (63.3) 27.9 (34.6) $ (0.6) $ (35.2) Balance at December 31, 2024 $ (14.8) $ (118.7) $ 2.3 $ (131.2) (1) Includes gain and losses on intra-entity foreign currency transactions that are of a long-term investment nature. (2) Amounts are net of tax. Pension and Currency Translation (1) Net Total Noncontrolling Total Balance at September 30, 2023 $ (34.5) $ (107.1) $ (5.5) $ (147.1) Other comprehensive income before reclassifications: Before tax amount (0.4) 49.3 0.3 49.2 $ — $ 49.2 Tax benefit 0.2 — (0.1) 0.1 — 0.1 After tax amount (0.2) 49.3 0.2 49.3 — 49.3 Amounts reclassified from accumulated other comprehensive loss (2) 6.2 — 0.7 6.9 — 6.9 Net current period other comprehensive income 6.0 49.3 0.9 56.2 $ — $ 56.2 Balance at December 31, 2023 $ (28.5) $ (57.8) $ (4.6) $ (90.9) (1) Includes gains and losses on intra-foreign currency transactions that are of a long-term investment nature. (2) Amounts are net of tax. Reclassifications out of accumulated other comprehensive loss include: Three Months Ended December 31, 2024 Amortization of Pension and (1) Loss on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Net revenue $ — $ — $ 0.3 $ 0.3 Operating expenses — — 0.5 0.5 Total before tax $ — $ — $ 0.8 $ 0.8 Tax expense (0.1) Total reclassifications for the period, net of tax $ 0.7 (1) These accumulated other comprehensive loss components are included in the computation of net periodic pension (benefit) cost (see Note 8). Three Months Ended December 31, 2023 Amortization of Pension and (1) (Gain) Loss on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Net revenue $ — $ — $ (0.1) $ (0.1) Cost of goods sold — — 0.3 0.3 Operating expenses 8.2 — 0.5 8.7 Total before tax $ 8.2 $ — $ 0.7 $ 8.9 Tax expense (2.0) Total reclassifications for the period, net of tax $ 6.9 (1) These accumulated other comprehensive loss components are included in the computation of net periodic pension (benefit) cost (see Note 8).

Share-Based Compensation

Share-Based Compensation	3 Months Ended
	Dec. 31, 2024
Compensation Related Costs [Abstract]
Share-Based Compensation	Share-Based Compensation Three Months Ended 2024 2023 Share-based compensation costs $ 4.7 $ 5.2 Less impact of income taxes 1.1 1.2 Share-based compensation costs, net of tax $ 3.6 $ 4.0 The Company has share-based compensation with long-term performance-based metrics that are contingent upon the Company’s relative total shareholder return and the creation of shareholder value, as well as time-based awards. Relative total shareholder return is determined by comparing the Company’s total shareholder return during a three-year period to the respective total shareholder returns of companies in a designated stock index. Creation of shareholder value is measured by the cumulative cash returns and final period net operating profit after tax compared to the established hurdle rate over a three-year period. For the performance-based awards contingent upon the creation of shareholder value, compensation expense is adjusted each quarter based upon actual results to date and any changes to forecasted information on each of the separate grants. During the three months ended December 31, 2024, the Company made the following grants: Number of Time-based stock awards 354,713 Performance-based stock awards (maximum that can be earned) 588,686 The Company’s time-based stock awards and performance-based stock awards granted during the three months ended December 31, 2024, had weighted-average grant date fair values of $33.62 and $40.06, respectively. Included in the performance-based stock awards granted during the three months ended December 31, 2024 are 294,386 units whose payout level is based upon the Company’s relative total shareholder return over the three-year measurement period, as described above. These units will be expensed on a straight-line basis over the measurement period and are not subsequently adjusted after the grant date.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies From time to time, Hillenbrand is involved in claims, lawsuits, and government proceedings relating to its operations, including environmental, antitrust, patent infringement, business practices, commercial transactions, product and general liability, workers’ compensation, auto liability, employment-related, and other matters. The ultimate outcome of any claims, lawsuits, and proceedings cannot be predicted with certainty. An estimated loss from these contingencies is recognized when the Company believes it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated; however, it is difficult to measure the actual loss that might be incurred related to these matters. If a loss is not considered probable or cannot be reasonably estimated, the Company is required to make a disclosure if there is at least a reasonable possibility that a significant loss may have been incurred. Legal fees associated with claims and lawsuits are generally expensed as incurred. Claims covered by insurance have in most instances deductibles and self-funded retentions up to $0.5 per occurrence or per claim, depending upon the type of coverage and policy period. For auto, workers’ compensation, and general liability claims in the U.S., outside insurance companies and third-party claims administrators generally assist in establishing individual claim reserves. An independent outside actuary often provides estimates of ultimate projected losses, including incurred but not reported claims, which are used to establish reserves for losses. For all other types of claims, reserves are established when payment is considered probable and are based upon advice from internal and external counsel and historical settlement information for such claims. The recorded amounts represent the best estimate of costs that the Company will incur in relation to such exposures, but it is possible that actual costs will differ from those estimates. At December 31, 2024 and September 30, 2024, the Company had $11.2, included in other current liabilities on the Consolidated Balance Sheets, related to a discrete commercial dispute stemming from a contract entered into with a Molding Technology Solutions’ customer prior to the Company’s acquisition of the Molding Technology Solutions reportable operating segment.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The authoritative guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability, developed based upon the best information available in the circumstances. The categorization of financial assets and liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is broken down into three levels: Level 1: Inputs are quoted prices in active markets for identical assets or liabilities. Level 2: Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) that are observable for the asset or liability, either directly or indirectly. Level 3: Inputs are unobservable for the asset or liability. See the section below titled “Valuation techniques” for further discussion of how Hillenbrand determines fair value for certain assets and liabilities. Carrying Value at December 31, 2024 Fair Value at December 31, 2024 Using Inputs Considered as: Level 1 Level 2 Level 3 Assets: Cash and cash equivalents $ 208.0 $ 208.0 $ — $ — DPP receivables 5.8 — 5.8 — Restricted cash 1.0 1.0 — — Restricted cash for benefit plan contributions 29.5 29.5 — — Investments in rabbi trust 5.5 5.5 — — Derivative instruments 22.3 — 22.3 — Liabilities: Revolving credit facility 329.0 — 329.0 — $200 term loan 180.0 — 180.0 — €185 term loan 180.9 — 180.9 — $350 senior unsecured notes 350.0 306.2 — — $375 senior unsecured notes 374.8 372.1 — — $500 senior unsecured notes 500.0 501.4 — — Derivative instruments 28.1 — 28.1 — Contingent consideration 14.6 — — 14.6 Carrying Value at September 30, 2024 Fair Value at September 30, 2024 Using Inputs Considered as: Level 1 Level 2 Level 3 Assets: Cash and cash equivalents $ 199.3 $ 199.3 $ — $ — DPP receivables 6.7 — 6.7 — Restricted cash 1.1 1.1 — — Restricted cash for benefit plan contributions 27.5 27.5 — — Investments in rabbi trust 4.8 4.8 — — Derivative instruments 19.0 — 19.0 — Liabilities: Revolving credit facility 298.5 — 298.5 — $200 term loan 182.5 — 182.5 — €185 term loan 196.5 — 196.5 — $350 senior unsecured notes 350.0 312.9 — — $375 senior unsecured notes 374.8 373.7 — — $500 senior unsecured notes 500.0 509.8 — — Derivative instruments 40.5 — 40.5 — Contingent consideration 14.6 — — 14.6 Valuation techniques • Cash and cash equivalents, restricted cash, restricted cash for benefit plan contributions, and investments in rabbi trust are classified within Level 1 of the fair value hierarchy. Financial instruments classified as Level 1 are based on quoted market prices in active markets. The types of financial instruments the Company classifies within Level 1 include most bank deposits, money market securities, and publicly traded mutual funds. The Company does not adjust the quoted market price for such financial instruments. • The DPP receivables fair value is based on a discounted cash flow analysis (estimated amount expected to be received) using historical experience and inputs from similar programs, which include the estimated timing of payments and the credit quality of the underlying creditor. Significant changes in any of the inputs in isolation would not result in a materially different fair value estimate. Based on the short-term nature of the DPP receivables, typically 90 -120 days, they are classified as a level 2 measurement. • The Company estimates the fair value of foreign currency derivatives using industry accepted models. The significant Level 2 inputs used in the valuation of derivatives include spot rates, forward rates, and volatility. These inputs were obtained from pricing services, broker quotes, and other sources. • The fair values of the amounts outstanding under the Facility, $200 term loan, and €185 term loan approximate carrying value, as the Company believes their variable interest rate terms correspond to current market terms, and therefore, are classified within Level 2 of the fair value hierarchy. • The fair values of the $350 senior unsecured notes, $375 senior unsecured notes, and $500 senior unsecured notes were based on quoted prices in active markets and are classified within Level 1 of the fair value hierarchy. The Company does not adjust the quoted market prices for such financial instruments. • The contingent consideration of $14.6 reflects the estimated fair value of contingent future cash payments to the previous owners of FPM for research and development tax credits that were generated by FPM prior to the acquisition date. The Company estimated the fair value of the contingent consideration based on the technical merits of the research and development tax credits using an internally developed analysis. The key inputs to this calculation include the nature of the research and development activities, personnel involved in the research and development activities, the level of research and development spend prior to acquisition by the Company, and interpretation of applicable tax law. The value of these credits is subject to audit by the tax authorities and to the closing of the statute of limitations for the year in which the tax credits are fully utilized, the timing of which is not able to be determined at this time, but we expect to extend several years. There have been no changes in the estimated fair value of the initial calculation of the contingent consideration during the three months ended December 31, 2024. The inputs for the liability are unobservable, and therefore, are classified within Level 3 of the fair value hierarchy. Derivative instruments Hillenbrand participates in cross-currency swap agreements aiming to hedge the variability in the movement of foreign currency exchange rates for its operations in Europe, while simultaneously lowering the Company’s overall borrowing costs. The maturity dates of these agreements range from 2027 to 2029. These agreements qualify for hedge accounting and accordingly the changes in the fair value of the derivatives are recorded in other comprehensive (loss) income and remain in accumulated other comprehensive loss attributable to Hillenbrand in shareholders’ equity until the hedged item is recognized in earnings. We assess the effectiveness of cross-currency swap contracts using the spot method, and the difference between the interest rate received and paid under the cross-currency swap agreements is recorded in interest expense, net, in the Consolidated Statements of Operations. As a result of participating in these cross-currency swap agreements, Hillenbrand recorded a reduction in interest expense, net of $3.2 and $0.0 during the three months ended December 31, 2024 and 2023, respectively. Hillenbrand presents the cross-currency swap agreements’ periodic settlements in operating activities in the Consolidated Statements of Cash Flows. The Company has hedging programs in place to manage its currency exposures. The objectives of the Company’s hedging programs are to mitigate exposures in gross margin and non-functional-currency-denominated assets and liabilities. Under these programs, the Company uses derivative financial instruments to manage the economic impact of fluctuations in currency exchange rates. These include foreign currency exchange forward contracts, which generally have terms up to 24 months.

Segment and Geographical Inform

Segment and Geographical Information	3 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Segment and Geographical Information	Segment and Geographical Information As previously described, on February 1, 2023, the Company completed the divestiture of Batesville. The operating results and cash flows for Batesville have been classified as discontinued operations within the Consolidated Financial Statements for all periods presented. Hillenbrand is composed of two reportable operating segments: Advanced Process Solutions and Molding Technology Solutions. The Company’s reportable operating segments maintain separate financial information for which results of operations are evaluated on a regular basis by the Company’s chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company records the direct costs of business operations to the reportable operating segments, including stock-based compensation, asset impairments, restructuring activities, and business acquisition costs. Corporate provides management and administrative services to each reportable operating segment. These services include treasury management, human resources, legal, business development, information technology, tax compliance, global supply management, sustainability, and other public company support functions such as internal audit, investor relations, and financial reporting. With limited exception for certain professional services and back-office and technology costs, the Company does not allocate these types of corporate expenses to the reportable operating segments. The following tables present financial information for the Company’s reportable operating segments and significant geographical locations: Three Months Ended December 31, 2024 2023 Net revenue Advanced Process Solutions $ 511.1 $ 568.3 Molding Technology Solutions 195.8 205.0 Total $ 706.9 $ 773.3 Adjusted EBITDA (1) Advanced Process Solutions $ 82.8 $ 96.0 Molding Technology Solutions 27.4 32.1 Corporate (13.1) (14.0) Net revenue (2) United States $ 284.7 $ 326.9 China 81.1 91.9 India 57.1 57.9 Germany 51.1 59.1 All other countries 232.9 237.5 Total $ 706.9 $ 773.3 (1) Adjusted earnings before interest, income tax, depreciation, and amortization (“adjusted EBITDA”) is a non-GAAP financial measure used by management to measure segment performance and make operating decisions. (2) The Company attributes net revenue to a geography based upon the location of the end customer. December 31, 2024 September 30, 2024 Total assets Advanced Process Solutions $ 3,331.7 $ 3,470.8 Molding Technology Solutions 1,551.2 1,600.0 Corporate 176.5 167.9 Total $ 5,059.4 $ 5,238.7 Tangible long-lived assets, net United States $ 184.1 $ 186.1 Germany 123.5 134.5 China 34.8 37.1 India 33.9 35.6 All other foreign business units 85.2 92.0 Total $ 461.5 $ 485.3 The following schedule reconciles reportable operating segment adjusted EBITDA to consolidated net income: Three Months Ended 2024 2023 Adjusted EBITDA: Advanced Process Solutions $ 82.8 $ 96.0 Molding Technology Solutions 27.4 32.1 Corporate (13.1) (14.0) Add: Loss from discontinued operations (net of income tax expense) — (0.3) Less: Interest expense, net 25.1 29.8 Income tax expense 6.4 10.0 Depreciation and amortization 37.9 38.8 Pension settlement (gain) charge (1.7) 8.3 Business acquisition, divestiture, and integration costs 18.1 5.6 Inventory step-up costs — 1.5 Restructuring and restructuring-related charges 2.4 0.6 Consolidated net income $ 8.9 $ 19.2

Subsequent Events

Subsequent Events	3 Months Ended
	Dec. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	16. Subsequent Event

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 6.4	$ 17.2

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy	Recently issued accounting standards In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures . ASU 2023-07 requires additional disclosures pertaining to significant expenses and other items of an entity’s reportable operating segments. ASU 2023-07 is effective for annual periods beginning after December 15, 2023 (fiscal 2025), and interim periods beginning in fiscal 2026. The Company is currently evaluating the impact of ASU 2023-07 on the Consolidated Financial Statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. ASU 2023-09 will be effective for annual periods beginning after December 15, 2024 (fiscal 2026). The Company is currently evaluating the impact of ASU 2023-09 on the Consolidated Financial Statements. In March 2024, the SEC adopted final rules requiring public entities to provide certain climate-related information in their registration statements and annual reports. As part of the disclosures, entities will be required to quantify certain effects of severe weather events and other natural conditions in a note to their audited financial statements. The rules will be effective for annual periods beginning in calendar 2025 (fiscal 2026). In April 2024, the SEC voluntarily stayed implementation of the final rules pending certain legal challenges. The Company is assessing the effect of the new rules on our Consolidated Financial Statements and related disclosures. In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (ASU 2024-03), which requires, among other items, additional disaggregated disclosures in the notes to financial statements for certain categories of expenses that are included on the face of the Consolidated Statement of Operations. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 (fiscal 2028), and for interim periods within fiscal years beginning after December 15, 2027 (fiscal 2029), with early adoption permitted. The Company is currently evaluating the impact of ASU 2024-03 on the Consolidated Financial Statements. No other new accounting pronouncements recently adopted or issued had or are expected to have a material impact on the Consolidated Financial Statements.
Revenue	Net revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services and is recognized when performance obligations are satisfied under the terms of contracts with customers.
Revenue Recognition, Deferred Revenue	Contract balances The balance in receivables from long-term manufacturing contracts at December 31, 2024 and September 30, 2024, was $289.5 and $302.7, respectively. The change was driven by the impact of net revenue recognized prior to billings to customers. The balance in the liabilities from long-term manufacturing contracts and advances at December 31, 2024 and September 30, 2024, was $293.8 and $315.2, respectively, and consists primarily of cash payments received or due in advance of satisfying performance obligations. The net revenue recognized for the three months ended December 31, 2024 and 2023, related to liabilities from long-term manufacturing contracts and advances as of September 30, 2024 and 2023, was $95.6 and $116.4, respectively. During the three months ended December 31, 2024 and 2023, the adjustments related to performance obligations satisfied in previous periods were immaterial.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Disaggregation of revenue The following tables present net revenue by geography: Three Months Ended December 31, 2024 Three Months Ended December 31, 2023 Advanced Process Solutions Molding Technology Solutions Total Advanced Process Solutions Molding Technology Solutions Total Geography (1) Americas $ 229.2 $ 102.9 $ 332.1 $ 264.2 $ 109.9 $ 374.1 Asia 128.8 60.2 189.0 146.3 60.5 206.8 Europe, the Middle East, and Africa 153.1 32.7 185.8 157.8 34.6 192.4 Total $ 511.1 $ 195.8 $ 706.9 $ 568.3 $ 205.0 $ 773.3 (1) The Company attributes net revenue to a geography based upon the location of the end customer. The following tables present net revenue by timing of transfer: Three Months Ended December 31, 2024 Three Months Ended December 31, 2023 Advanced Process Solutions Molding Technology Solutions Total Advanced Process Solutions Molding Technology Solutions Total Timing of transfer Point in time $ 269.8 $ 181.1 $ 450.9 $ 278.2 $ 186.4 $ 464.6 Over time 241.3 14.7 256.0 290.1 18.6 308.7 Total $ 511.1 $ 195.8 $ 706.9 $ 568.3 $ 205.0 $ 773.3

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	3 Months Ended
	Dec. 31, 2024
Balance Sheet Related Disclosures [Abstract]
Schedule of supplemental balance sheet information	December 31, 2024 September 30, 2024 Allowance for credit losses $ 13.7 $ 13.6 Warranty reserves $ 46.7 $ 47.9 Accumulated depreciation on property, plant, and equipment $ 268.7 $ 265.6 Inventories, net: Raw materials and components $ 248.1 $ 247.0 Work in process 120.1 127.6 Finished goods 153.5 150.6 Total inventories, net $ 521.7 $ 525.2 The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the Consolidated Balance Sheets that sum to the total of the same amounts shown in the Consolidated Statements of Cash Flows: December 31, 2024 December 31, 2023 Cash and cash equivalents $ 208.0 $ 198.4 Short-term restricted cash included in other current assets 6.9 1.2 Long-term restricted cash included in other long-term assets 23.6 — Total cash and cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows $ 238.5 $ 199.6
Fair Value Option, Disclosures	The following roll forward summarizes the activity related to the DPP receivables: Three Months Ended December 31, 2024 Three Months Ended December 31, 2023 Beginning DPP receivables balance $ 6.7 $ — Non-cash additions to DPP receivables 9.2 — Cash collections on DPP receivables (10.1) — Ending DPP receivables balance $ 5.8 $ —

Leases (Tables)

Leases (Tables)	3 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Schedule of Supplemental Balance Sheet Information	The following table presents supplemental Consolidated Balance Sheet information related to the Company’s operating leases: December 31, 2024 September 30, 2024 Operating lease right-of-use assets, net $ 157.8 $ 168.7 Other current liabilities 20.5 22.0 Operating lease liabilities 131.8 141.1 Total operating lease liabilities $ 152.3 $ 163.1 Weighted-average remaining lease term (in years) 10.1 10.3 Weighted-average discount rate 6.3 % 6.3 %
Schedule of Operating Lease Liability Maturities	As of December 31, 2024, the maturities of the Company’s operating lease liabilities were as follows: 2025 (excluding the three months ended December 31, 2024) $ 21.4 2026 25.9 2027 23.0 2028 20.8 2029 19.2 Thereafter 111.4 Total lease payments 221.7 Less: imputed interest (69.4) Total present value of lease payments $ 152.3
Schedule of Supplemental Statement of Cash Flow Information	Supplemental Consolidated Statements of Cash Flow information related to the Company’s operating leases is as follows: Three Months Ended December 31, 2024 2023 Cash paid for amounts included in the measurement of operating lease liabilities $ 8.0 $ 6.8 Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities 4.6 4.9 Operating leases acquired in business combinations — 3.5

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	3 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The following table summarizes the carrying amounts and related accumulated amortization for intangible assets as of: December 31, 2024 September 30, 2024 Cost Accumulated Cost Accumulated Finite-lived assets: Customer relationships $ 1,278.6 $ (386.8) $ 1,316.9 $ (379.4) Technology, including patents 189.3 (101.8) 192.3 (100.9) Software 56.4 (38.9) 53.0 (35.3) Trade names 50.2 (11.5) 52.5 (10.6) 1,574.5 (539.0) 1,614.7 (526.2) Indefinite-lived assets: Trade names 193.9 — 197.4 — Total $ 1,768.4 $ (539.0) $ 1,812.1 $ (526.2)
Schedule of Goodwill	The following table summarizes the changes in the Company’s goodwill, by reportable operating segment, for the three months ended December 31, 2024: Advanced Process Solutions Molding Technology Solutions Total Balance as of September 30, 2024 $ 1,430.2 $ 405.5 $ 1,835.7 Foreign currency adjustments (48.7) (7.9) (56.6) Balance as of December 31, 2024 $ 1,381.5 $ 397.6 $ 1,779.1

Financing Agreements (Tables)

Financing Agreements (Tables)	3 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of borrowings under financing agreements	The following table summarizes Hillenbrand’s current and long-term debt as of: December 31, 2024 September 30, 2024 $1,000 revolving credit facility (excluding outstanding letters of credit) $ 329.0 $ 298.5 $200 term loan 180.0 182.5 €185 term loan 180.9 196.5 $500 senior unsecured notes (1) 495.0 494.6 $375 senior unsecured notes (2) 373.8 373.6 $350 senior unsecured notes (3) 347.2 347.1 Other — 0.2 Total debt 1,905.9 1,893.0 Less: current portion 20.9 20.6 Total long-term debt $ 1,885.0 $ 1,872.4 (1) Includes unamortized debt issuance costs of $5.0 and $5.4 at December 31, 2024 and September 30, 2024, respectively. (2) Includes unamortized debt issuance costs of $1.0 and $1.2 at December 31, 2024 and September 30, 2024, respectively. (3) Includes unamortized debt issuance costs of $2.8 and $2.9 at December 31, 2024 and September 30, 2024, respectively.

Retirement Benefits (Tables)

Retirement Benefits (Tables)	3 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Components of net pension costs	Components of net periodic pension (benefit) cost included in the Consolidated Statements of Operations were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits Three Months Ended December 31, Three Months Ended December 31, 2024 2023 2024 2023 Service costs $ — $ — $ 0.7 $ 0.5 Interest costs 0.2 2.0 0.8 1.1 Expected return on plan assets — (2.7) (0.3) (0.4) Amortization of net loss (gain) — 0.1 (0.2) (0.2) Settlement (gain) charge (1.7) 8.3 — — Net periodic pension (benefit) cost $ (1.5) $ 7.7 $ 1.0 $ 1.0

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Schedule of computation of basic and diluted earnings per share	Three Months Ended 2024 2023 Income from continuing operations $ 8.9 $ 19.5 Less: Net income attributable to noncontrolling interests 2.5 2.0 Income from continuing operations attributable to Hillenbrand $ 6.4 $ 17.5 Weighted-average shares outstanding (basic - in millions) 70.6 70.3 Effect of dilutive stock options and other unvested equity awards (in millions) — 0.2 Weighted-average shares outstanding (diluted - in millions) 70.6 70.5 Basic earnings per share from continuing operations attributable to Hillenbrand $ 0.09 $ 0.25 Diluted earnings per share from continuing operations attributable to Hillenbrand $ 0.09 $ 0.25 Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions) 0.9 0.6

Other Comprehensive Income (Los

Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Dec. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of changes in accumulated other comprehensive income (loss) by component	The following tables summarize the changes in the accumulated balances for each component of accumulated other comprehensive loss: Pension and Currency Translation (1) Net Total Noncontrolling Total Balance at September 30, 2024 $ (15.6) $ (55.4) $ (25.6) $ (96.6) Other comprehensive loss before reclassifications: Before tax amount 1.1 (63.3) 26.5 (35.7) $ (0.6) $ (36.3) Tax benefit (0.3) — 0.7 0.4 — 0.4 After tax amount 0.8 (63.3) 27.2 (35.3) (0.6) (35.9) Amounts reclassified from accumulated other comprehensive loss (2) — — 0.7 0.7 — 0.7 Net current period other comprehensive income (loss) 0.8 (63.3) 27.9 (34.6) $ (0.6) $ (35.2) Balance at December 31, 2024 $ (14.8) $ (118.7) $ 2.3 $ (131.2) (1) Includes gain and losses on intra-entity foreign currency transactions that are of a long-term investment nature. (2) Amounts are net of tax. Pension and Currency Translation (1) Net Total Noncontrolling Total Balance at September 30, 2023 $ (34.5) $ (107.1) $ (5.5) $ (147.1) Other comprehensive income before reclassifications: Before tax amount (0.4) 49.3 0.3 49.2 $ — $ 49.2 Tax benefit 0.2 — (0.1) 0.1 — 0.1 After tax amount (0.2) 49.3 0.2 49.3 — 49.3 Amounts reclassified from accumulated other comprehensive loss (2) 6.2 — 0.7 6.9 — 6.9 Net current period other comprehensive income 6.0 49.3 0.9 56.2 $ — $ 56.2 Balance at December 31, 2023 $ (28.5) $ (57.8) $ (4.6) $ (90.9) (1) Includes gains and losses on intra-foreign currency transactions that are of a long-term investment nature. (2) Amounts are net of tax.
Schedule of reclassifications of AOCI	Reclassifications out of accumulated other comprehensive loss include: Three Months Ended December 31, 2024 Amortization of Pension and (1) Loss on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Net revenue $ — $ — $ 0.3 $ 0.3 Operating expenses — — 0.5 0.5 Total before tax $ — $ — $ 0.8 $ 0.8 Tax expense (0.1) Total reclassifications for the period, net of tax $ 0.7 (1) These accumulated other comprehensive loss components are included in the computation of net periodic pension (benefit) cost (see Note 8). Three Months Ended December 31, 2023 Amortization of Pension and (1) (Gain) Loss on Net Loss Prior Service Costs Derivative Total Affected Line in the Consolidated Statement of Operations: Net revenue $ — $ — $ (0.1) $ (0.1) Cost of goods sold — — 0.3 0.3 Operating expenses 8.2 — 0.5 8.7 Total before tax $ 8.2 $ — $ 0.7 $ 8.9 Tax expense (2.0) Total reclassifications for the period, net of tax $ 6.9 (1) These accumulated other comprehensive loss components are included in the computation of net periodic pension (benefit) cost (see Note 8).

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
	Dec. 31, 2024
Compensation Related Costs [Abstract]
Schedule of stock-based compensation costs	Three Months Ended 2024 2023 Share-based compensation costs $ 4.7 $ 5.2 Less impact of income taxes 1.1 1.2 Share-based compensation costs, net of tax $ 3.6 $ 4.0
Schedule of stock-based awards granted in the period	During the three months ended December 31, 2024, the Company made the following grants: Number of Time-based stock awards 354,713 Performance-based stock awards (maximum that can be earned) 588,686

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of financial assets and liabilities at carrying value and fair value and the level within the fair value hierarchy	Carrying Value at December 31, 2024 Fair Value at December 31, 2024 Using Inputs Considered as: Level 1 Level 2 Level 3 Assets: Cash and cash equivalents $ 208.0 $ 208.0 $ — $ — DPP receivables 5.8 — 5.8 — Restricted cash 1.0 1.0 — — Restricted cash for benefit plan contributions 29.5 29.5 — — Investments in rabbi trust 5.5 5.5 — — Derivative instruments 22.3 — 22.3 — Liabilities: Revolving credit facility 329.0 — 329.0 — $200 term loan 180.0 — 180.0 — €185 term loan 180.9 — 180.9 — $350 senior unsecured notes 350.0 306.2 — — $375 senior unsecured notes 374.8 372.1 — — $500 senior unsecured notes 500.0 501.4 — — Derivative instruments 28.1 — 28.1 — Contingent consideration 14.6 — — 14.6 Carrying Value at September 30, 2024 Fair Value at September 30, 2024 Using Inputs Considered as: Level 1 Level 2 Level 3 Assets: Cash and cash equivalents $ 199.3 $ 199.3 $ — $ — DPP receivables 6.7 — 6.7 — Restricted cash 1.1 1.1 — — Restricted cash for benefit plan contributions 27.5 27.5 — — Investments in rabbi trust 4.8 4.8 — — Derivative instruments 19.0 — 19.0 — Liabilities: Revolving credit facility 298.5 — 298.5 — $200 term loan 182.5 — 182.5 — €185 term loan 196.5 — 196.5 — $350 senior unsecured notes 350.0 312.9 — — $375 senior unsecured notes 374.8 373.7 — — $500 senior unsecured notes 500.0 509.8 — — Derivative instruments 40.5 — 40.5 — Contingent consideration 14.6 — — 14.6

Segment and Geographical Info_2

Segment and Geographical Information (Tables)	3 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Schedule of net revenue, adjusted EBITDA, and depreciation and amortization by segment and geographic location	The following tables present financial information for the Company’s reportable operating segments and significant geographical locations: Three Months Ended December 31, 2024 2023 Net revenue Advanced Process Solutions $ 511.1 $ 568.3 Molding Technology Solutions 195.8 205.0 Total $ 706.9 $ 773.3 Adjusted EBITDA (1) Advanced Process Solutions $ 82.8 $ 96.0 Molding Technology Solutions 27.4 32.1 Corporate (13.1) (14.0) Net revenue (2) United States $ 284.7 $ 326.9 China 81.1 91.9 India 57.1 57.9 Germany 51.1 59.1 All other countries 232.9 237.5 Total $ 706.9 $ 773.3 (1) Adjusted earnings before interest, income tax, depreciation, and amortization (“adjusted EBITDA”) is a non-GAAP financial measure used by management to measure segment performance and make operating decisions. (2)
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas	December 31, 2024 September 30, 2024 Total assets Advanced Process Solutions $ 3,331.7 $ 3,470.8 Molding Technology Solutions 1,551.2 1,600.0 Corporate 176.5 167.9 Total $ 5,059.4 $ 5,238.7 Tangible long-lived assets, net United States $ 184.1 $ 186.1 Germany 123.5 134.5 China 34.8 37.1 India 33.9 35.6 All other foreign business units 85.2 92.0 Total $ 461.5 $ 485.3
Schedule of reconciliation of segment adjusted EBITDA to consolidated net income	The following schedule reconciles reportable operating segment adjusted EBITDA to consolidated net income: Three Months Ended 2024 2023 Adjusted EBITDA: Advanced Process Solutions $ 82.8 $ 96.0 Molding Technology Solutions 27.4 32.1 Corporate (13.1) (14.0) Add: Loss from discontinued operations (net of income tax expense) — (0.3) Less: Interest expense, net 25.1 29.8 Income tax expense 6.4 10.0 Depreciation and amortization 37.9 38.8 Pension settlement (gain) charge (1.7) 8.3 Business acquisition, divestiture, and integration costs 18.1 5.6 Inventory step-up costs — 1.5 Restructuring and restructuring-related charges 2.4 0.6 Consolidated net income $ 8.9 $ 19.2

Background and Basis of Prese_2

Background and Basis of Presentation - Narrative (Details) $ in Millions		3 Months Ended
	Feb. 01, 2023 USD ($)	Dec. 31, 2024 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments | segment		2
Acquired entity subsidiary investments owned percent		100%
Batesville | Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total transaction value	$ 761.5
Consideration from sale of segment, subordinated note	$ 11.5

Revenue Recognition Narrative (

Revenue Recognition Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Receivables from long-term manufacturing contracts, net	$ 289.5		$ 302.7
Liabilities from long-term manufacturing contracts and advances	293.8		$ 315.2
Revenue recognized on long-term manufacturing contracts and advances liabilities	$ 95.6	$ 116.4

Revenue Recognition Revenue Rem

Revenue Recognition Revenue Remaining Performance Obligation Narrative (Details) $ in Millions	Dec. 31, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 1,816.7
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	12 months
Remaining performance obligation expected to be recognized in the given period (as a percent)	88%

Revenue Recognition by Geograph

Revenue Recognition by Geographic Markets (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Net revenue	$ 706.9	$ 773.3
Americas
Disaggregation of Revenue [Line Items]
Net revenue	332.1	374.1
Asia
Disaggregation of Revenue [Line Items]
Net revenue	189	206.8
Europe, the Middle East, and Africa
Disaggregation of Revenue [Line Items]
Net revenue	185.8	192.4
Process Equipment Group [Member]
Disaggregation of Revenue [Line Items]
Net revenue	511.1	568.3
Process Equipment Group [Member] | Americas
Disaggregation of Revenue [Line Items]
Net revenue	229.2	264.2
Process Equipment Group [Member] | Asia
Disaggregation of Revenue [Line Items]
Net revenue	128.8	146.3
Process Equipment Group [Member] | Europe, the Middle East, and Africa
Disaggregation of Revenue [Line Items]
Net revenue	153.1	157.8
Milacron [Member]
Disaggregation of Revenue [Line Items]
Net revenue	195.8	205
Milacron [Member] | Americas
Disaggregation of Revenue [Line Items]
Net revenue	102.9	109.9
Milacron [Member] | Asia
Disaggregation of Revenue [Line Items]
Net revenue	60.2	60.5
Milacron [Member] | Europe, the Middle East, and Africa
Disaggregation of Revenue [Line Items]
Net revenue	$ 32.7	$ 34.6

Revenue Recognition Timing of T

Revenue Recognition Timing of Transfer (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Net revenue	$ 706.9	$ 773.3
Point in time
Disaggregation of Revenue [Line Items]
Net revenue	450.9	464.6
Over time
Disaggregation of Revenue [Line Items]
Net revenue	256	308.7
Process Equipment Group [Member]
Disaggregation of Revenue [Line Items]
Net revenue	511.1	568.3
Process Equipment Group [Member] | Point in time
Disaggregation of Revenue [Line Items]
Net revenue	269.8	278.2
Process Equipment Group [Member] | Over time
Disaggregation of Revenue [Line Items]
Net revenue	241.3	290.1
Milacron [Member]
Disaggregation of Revenue [Line Items]
Net revenue	195.8	205
Milacron [Member] | Point in time
Disaggregation of Revenue [Line Items]
Net revenue	181.1	186.4
Milacron [Member] | Over time
Disaggregation of Revenue [Line Items]
Net revenue	$ 14.7	$ 18.6

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information - Schedule of supplemental balance sheet information (Details) - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Balance Sheet Related Disclosures [Abstract]
Allowance for credit losses	$ 13.7	$ 13.6
Warranty reserves	46.7	47.9
Accumulated depreciation on property, plant, and equipment	268.7	265.6
Inventories, net:
Raw materials and components	248.1	247
Work in process	120.1	127.6
Finished goods	153.5	150.6
Total inventories, net	521.7	525.2
Cash and cash equivalents	208	199.3	$ 198.4
Short-term restricted cash included in other current assets	6.9		1.2
Long-term restricted cash included in other long-term assets	23.6		0
Total cash and cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows	$ 238.5	$ 227.9	$ 199.6	$ 250.2

Supplemental Balance Sheet In_4

Supplemental Balance Sheet Information - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Sep. 30, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Trade receivables, net	$ 309.5		$ 350.1
Proceeds from Collection of Other Receivables	71.7	$ 7.2
Equity Method Investments	12		9.2
Income (Loss) from Equity Method Investments	$ 2.8	1.5
TerraSource Holdings, LLC
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Equity Method Investment, Ownership Percentage	46%
Trade Accounts Receivable
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from Sale of Other Receivables	$ 70.8	$ 7.2
Trade receivables, net	28.5		34.2
Supplier Finance Program
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Contractual Obligation	14.4		16
Trade receivables, net	$ 2.2		$ 3.1

Supplemental Balance Sheet In_5

Supplemental Balance Sheet Information - DPP Receivables (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Receivable Roll Forward [Roll Forward]
Beginning DPP receivables balance	$ 6.7	$ 0
Non-cash additions to DPP receivables	9.2	0
Collection of deferred purchase price receivables	(10.1)	0
Ending DPP receivables balance	$ 5.8	$ 0

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Operating lease expense	$ 10.5	$ 8.5

Leases - Schedule of Supplement

Leases - Schedule of Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Leases [Abstract]
Operating lease right-of-use assets, net	$ 157.8	$ 168.7
Other current liabilities	20.5	22
Operating lease liabilities	131.8	141.1
Total operating lease liabilities	$ 152.3	$ 163.1
Weighted-average remaining lease term (in years)	10 years 1 month 6 days	10 years 3 months 18 days
Weighted-average discount rate	6.30%	6.30%

Leases - Schedule of Operating

Leases - Schedule of Operating Lease Liability Maturities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Leases [Abstract]
2025 (excluding the three months ended December 31, 2024)	$ 21.4
2026	25.9
2027	23
2028	20.8
2029	19.2
Thereafter	111.4
Total lease payments	221.7
Less: imputed interest	(69.4)
Total present value of lease payments	$ 152.3	$ 163.1

Leases - Schedule of Suppleme_2

Leases - Schedule of Supplemental Statement of Cash Flow Information (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 8	$ 6.8
Operating lease right-of-use assets, net obtained in exchange for new operating lease liabilities	4.6	4.9
Operating leases acquired in business combinations	$ 0	$ 3.5

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Advanced Process Solutions
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net	$ 658.6	$ 693
Indefinite-lived assets:	108.8	112.3
Molding Technology Solutions
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net	369.7	388.3
Indefinite-lived assets:	$ 85.1	$ 85.1
Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	3 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	21 years

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Intangible Assets (Details) - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024
Intangible Assets [Line Items]
Cost	$ 1,574.5	$ 1,614.7
Accumulated Amortization	(539)	(526.2)
Total	1,768.4	1,812.1
Trade names
Intangible Assets [Line Items]
Indefinite-lived assets:	193.9	197.4
Customer relationships
Intangible Assets [Line Items]
Cost	1,278.6	1,316.9
Accumulated Amortization	(386.8)	(379.4)
Trade names
Intangible Assets [Line Items]
Cost	189.3	192.3
Accumulated Amortization	(101.8)	(100.9)
Software
Intangible Assets [Line Items]
Cost	56.4	53
Accumulated Amortization	(38.9)	(35.3)
Trade names
Intangible Assets [Line Items]
Cost	50.2	52.5
Accumulated Amortization	$ (11.5)	$ (10.6)

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Goodwill (Details) $ in Millions	3 Months Ended
	Dec. 31, 2024 USD ($)
Goodwill [Roll Forward]
Balance at the beginning of the period	$ 1,835.7
Foreign currency adjustments	(56.6)
Balance at the end of the period	1,779.1
Process Equipment Group [Member]
Goodwill [Roll Forward]
Balance at the beginning of the period	1,430.2
Foreign currency adjustments	(48.7)
Balance at the end of the period	1,381.5
Milacron [Member]
Goodwill [Roll Forward]
Balance at the beginning of the period	405.5
Foreign currency adjustments	(7.9)
Balance at the end of the period	$ 397.6

Financing Agreements - Schedule

Financing Agreements - Schedule of borrowings (Details)	Dec. 31, 2024 USD ($)	Sep. 30, 2024 USD ($)	Feb. 14, 2024 USD ($)	Jun. 21, 2023 EUR (€)	Jun. 08, 2022 USD ($)	Mar. 03, 2021 USD ($)	Sep. 25, 2019 USD ($)
Debt Instrument [Line Items]
Total debt	$ 1,905,900,000	$ 1,893,000,000
Current portion of long-term debt	20,900,000	20,600,000
Long-term debt	1,885,000,000	1,872,400,000
Former Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity					$ 1,000,000,000
$375 senior unsecured notes (2)
Debt Instrument [Line Items]
Debt instrument, face amount						$ 350,000,000
$1,000 revolving credit facility (excluding outstanding letters of credit)
Debt Instrument [Line Items]
Total debt	329,000,000	298,500,000
$1,000 revolving credit facility (excluding outstanding letters of credit) | Fourth Amended And Restated Credit Agreement | $200 term loan
Debt Instrument [Line Items]
Debt Instrument, Delayed Draw, Amount					$ 200,000,000
$1,000 revolving credit facility (excluding outstanding letters of credit) | 185 Euro Term Loan
Debt Instrument [Line Items]
Long-Term Line of Credit | €				€ 185,000,000
$200 term loan
Debt Instrument [Line Items]
Total debt	180,000,000	182,500,000
$500 senior unsecured notes (1)
Debt Instrument [Line Items]
Total debt	495,000,000	494,600,000
Debt Issuance Costs, Line of Credit Arrangements, Gross	5,000,000	5,400,000
$400 senior unsecured notes (2) | Twenty Twenty Four Senior Unsecured Notes Due February Twenty Twenty Nine
Debt Instrument [Line Items]
Debt instrument, face amount			$ 500,000,000
$400 senior unsecured notes (2) | 2019 Notes
Debt Instrument [Line Items]
Debt instrument, face amount							$ 375,000,000
$375 senior unsecured notes (2)
Debt Instrument [Line Items]
Total debt	373,800,000	373,600,000
Debt Issuance Costs, Line of Credit Arrangements, Gross	1,000,000	1,200,000
$350 senior unsecured notes (3)
Debt Instrument [Line Items]
Total debt	347,200,000	347,100,000
Debt Issuance Costs, Line of Credit Arrangements, Gross	2,800,000	2,900,000
Term Loan | Term Loan 225 Million
Debt Instrument [Line Items]
Total debt	180,900,000	196,500,000
Notes Payable, Other Payables
Debt Instrument [Line Items]
Total debt	0	$ 200,000
$200 Term Loan And 185 Term Loan
Debt Instrument [Line Items]
Debt Issuance Costs, Line of Credit Arrangements, Gross	$ 5,000,000

Financing Agreements - Narrativ

Financing Agreements - Narrative (Details)	3 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2023	Sep. 30, 2024 USD ($)	Jun. 21, 2023 EUR (€)	Jun. 08, 2022 USD ($)
Debt Instrument [Line Items]
Current borrowing capacity	$ 424,300,000
L/G Facility Agreement Amendment
Debt Instrument [Line Items]
Debt Issuance Costs, Line of Credit Arrangements, Gross	$ 1,400,000
$200 term loan | Debt Instrument, Tranche One
Debt Instrument [Line Items]
Weighted-average interest rates	6.69%
$200 term loan | Debt Instrument, Tranche Two
Debt Instrument [Line Items]
Weighted-average interest rates	5.60%
185 Euro Term Loan | Debt Instrument, Tranche One
Debt Instrument [Line Items]
Weighted-average interest rates	5.05%	5.60%
$1,000 revolving credit facility (excluding outstanding letters of credit)
Debt Instrument [Line Items]
Letters of credit outstanding, amount	$ 17,700,000
Line of credit facility, remaining borrowing capacity	$ 653,300,000
Weighted average facility fee	0.24%	0.20%
$1,000 revolving credit facility (excluding outstanding letters of credit) | Debt Instrument, Tranche One
Debt Instrument [Line Items]
Weighted-average interest rates	4.96%
$1,000 revolving credit facility (excluding outstanding letters of credit) | Debt Instrument, Tranche Two
Debt Instrument [Line Items]
Weighted-average interest rates	5.84%
$1,000 revolving credit facility (excluding outstanding letters of credit) | Fourth Amended And Restated Credit Agreement | $200 term loan
Debt Instrument [Line Items]
Debt Instrument, Delayed Draw, Amount					$ 200,000,000
$1,000 revolving credit facility (excluding outstanding letters of credit) | 185 Euro Term Loan
Debt Instrument [Line Items]
Long-Term Line of Credit | €				€ 185,000,000
$350 senior unsecured notes (3)
Debt Instrument [Line Items]
Debt Issuance Costs, Line of Credit Arrangements, Gross	$ 2,800,000		$ 2,900,000
Other Financing Agreements
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	561,300,000		594.3
Line of credit facility, amount utilized for bank guarantees	331,700,000		400.2
$500 senior unsecured notes (1)
Debt Instrument [Line Items]
Debt Issuance Costs, Line of Credit Arrangements, Gross	$ 5,000,000		$ 5,400,000

Retirement Benefits (Details)

Retirement Benefits (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Pension settlement (gain) charge	$ 1.7	$ (8.3)
U.S. Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Service costs	0	0
Interest costs	0.2	2
Expected return on plan assets	0	(2.7)
Amortization of net loss (gain)	0	0.1
Pension settlement (gain) charge	1.7	(8.3)
Net periodic pension (benefit) cost	(1.5)	7.7
Non-U.S. Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Service costs	0.7	0.5
Interest costs	0.8	1.1
Expected return on plan assets	(0.3)	(0.4)
Amortization of net loss (gain)	(0.2)	(0.2)
Pension settlement (gain) charge	0	0
Net periodic pension (benefit) cost	$ 1	$ 1

Retirement Benefits - Narrative

Retirement Benefits - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Retirement Benefits [Abstract]
Defined contribution plan expense	$ 3.1	$ 2.9

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate	41.80%	33.90%

Earnings Per Share - Narrative

Earnings Per Share - Narrative (Details) - shares	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Antidilutive securities excluded from computation of earnings per share [Line Items]
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions)	900,000	600,000
Performance-based stock awards (maximum that can be earned)
Antidilutive securities excluded from computation of earnings per share [Line Items]
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions)	630,000	440,000

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Earnings Per Share [Abstract]
Income from continuing operations	$ 8.9	$ 19.5
Less: Net income attributable to noncontrolling interests	2.5	2
Income from continuing operations attributable to Hillenbrand	$ 6.4	$ 17.5
Weighted average shares outstanding (basic)	70.6	70.3
Effect of dilutive stock options and other unvested equity awards (in millions)	0	0.2
Weighted-average shares outstanding (diluted - in millions)	70.6	70.5
Income from continuing operations attributable to Hillenbrand (in dollars per share)	$ 0.09	$ 0.25
Income from continuing operations attributable to Hillenbrand (in dollars per share)	$ 0.09	$ 0.25
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions)	0.9	0.6

Other Comprehensive Income (L_2

Other Comprehensive Income (Loss) - Schedule of changes in accumulated other comprehensive income (loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period	$ (96.6)
Other comprehensive income before reclassifications
Before tax amount	(36.3)	$ 49.2
Tax benefit	0.4	0.1
After tax amount	(35.9)	49.3
Amounts reclassified from accumulated other comprehensive loss (2)	0.7	6.9
Total changes in other comprehensive (loss) income, net of tax	(35.2)	56.2
Balance at the end of the period	(131.2)
Pension and Postretirement
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period	(15.6)	(34.5)
Other comprehensive income before reclassifications
Before tax amount	1.1	(0.4)
Tax benefit	(0.3)	0.2
After tax amount	0.8	(0.2)
Amounts reclassified from accumulated other comprehensive loss (2)	0	6.2
Total changes in other comprehensive (loss) income, net of tax	0.8	6
Balance at the end of the period	(14.8)	(28.5)
Currency Translation (1)
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period	(55.4)	(107.1)
Other comprehensive income before reclassifications
Before tax amount	(63.3)	49.3
Tax benefit	0	0
After tax amount	(63.3)	49.3
Amounts reclassified from accumulated other comprehensive loss (2)	0	0
Total changes in other comprehensive (loss) income, net of tax	(63.3)	49.3
Balance at the end of the period	(118.7)	(57.8)
Net Unrealized (Loss) Gain on Derivative Instruments
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period	(25.6)	(5.5)
Other comprehensive income before reclassifications
Before tax amount	26.5	0.3
Tax benefit	0.7	(0.1)
After tax amount	27.2	0.2
Amounts reclassified from accumulated other comprehensive loss (2)	0.7	0.7
Total changes in other comprehensive (loss) income, net of tax	27.9	0.9
Balance at the end of the period	2.3	(4.6)
Total Attributable to Hillenbrand, Inc.
Accumulated Other Comprehensive Income (Loss), before Tax [Roll Forward]
Balance at the beginning of the period	(96.6)	(147.1)
Other comprehensive income before reclassifications
Before tax amount	(35.7)	49.2
Tax benefit	0.4	0.1
After tax amount	(35.3)	49.3
Amounts reclassified from accumulated other comprehensive loss (2)	0.7	6.9
Total changes in other comprehensive (loss) income, net of tax	(34.6)	56.2
Balance at the end of the period	(131.2)	(90.9)
Noncontrolling Interests
Other comprehensive income before reclassifications
Before tax amount	(0.6)	0
Tax benefit	0	0
After tax amount	(0.6)	0
Amounts reclassified from accumulated other comprehensive loss (2)	0	0
Total changes in other comprehensive (loss) income, net of tax	$ (0.6)	$ 0

Other Comprehensive Income (L_3

Other Comprehensive Income (Loss) - Schedule of reclassifications (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Affected Line in the Consolidated Statement of Operations:
Net revenue	$ 706.9	$ 773.3
Cost of Goods and Services Sold	(471.9)	(522.3)
Tax expense	(6.4)	(10)
Total reclassifications for the period, net of tax	0.7	6.9
Amortization of Pension and Postretirement
Affected Line in the Consolidated Statement of Operations:
Total reclassifications for the period, net of tax	0	6.2
Loss (Gain) on Derivative Instruments
Affected Line in the Consolidated Statement of Operations:
Total reclassifications for the period, net of tax	0.7	0.7
Reclassifications out of accumulated other comprehensive income (loss)
Affected Line in the Consolidated Statement of Operations:
Net revenue	0.3	(0.1)
Operating expenses	0.5	(8.7)
Cost of Goods and Services Sold		0.3
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0.8	8.9
Tax expense	(0.1)	(2)
Total reclassifications for the period, net of tax	0.7	6.9
Reclassifications out of accumulated other comprehensive income (loss) | Accumulated Defined Benefit Plans Adjustment Net Loss Recognized [Member]
Affected Line in the Consolidated Statement of Operations:
Net revenue	0	0
Operating expenses	0	(8.2)
Cost of Goods and Services Sold		0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0	8.2
Reclassifications out of accumulated other comprehensive income (loss) | Accumulated Defined Benefit Plans Adjustment Prior Service Cost Recognized [Member]
Affected Line in the Consolidated Statement of Operations:
Net revenue	0	0
Operating expenses	0	0
Cost of Goods and Services Sold		0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0	0
Reclassifications out of accumulated other comprehensive income (loss) | Loss (Gain) on Derivative Instruments
Affected Line in the Consolidated Statement of Operations:
Net revenue	0.3	(0.1)
Operating expenses	0.5	(0.5)
Cost of Goods and Services Sold		0.3
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	$ 0.8	$ 0.7

Share-Based Compensation - Sche

Share-Based Compensation - Schedule of stock-based compensation costs (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Compensation Related Costs [Abstract]
Share-based compensation costs	$ 4.7	$ 5.2
Less impact of income taxes	1.1	1.2
Share-based compensation costs, net of tax	$ 3.6	$ 4

Share-Based Compensation - Sc_2

Share-Based Compensation - Schedule of stock-based awards granted (Details)	3 Months Ended
	Dec. 31, 2024 shares
Time-based stock awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards granted in period (in shares)	354,713
Performance-based stock awards (maximum that can be earned)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards granted in period (in shares)	588,686

Share-Based Compensation - Narr

Share-Based Compensation - Narrative (Details)	3 Months Ended
	Dec. 31, 2024 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years)	3 years
Time-based stock awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grant date fair value (in dollars per share)	$ 33.62
Performance-based stock awards (maximum that can be earned)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity instruments other than options, grant date fair value (in dollars per share)	$ 40.06
Performance-based stock awards granted, number of units (in shares) | shares	294,386

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Sep. 30, 2024
Molding Technology Solutions
Commitments and Contingencies
Loss Contingency Accrual	$ 11.2	$ 11.2
General claims and lawsuits | Minimum
Commitments and Contingencies
Deductibles and self-insured retentions per occurrence or per claim	$ 0.5

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of financial assets and liabilities (Details)	3 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Sep. 30, 2024 USD ($)	Feb. 14, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 01, 2023 USD ($)	Jun. 21, 2023 USD ($)	Jun. 21, 2023 EUR (€)	Mar. 03, 2021 USD ($)	Sep. 25, 2019 USD ($)
Assets:
Cash and cash equivalents	$ 208,000,000
Receivables, Fair Value Disclosure	5,800,000	$ 0	$ 6,700,000		$ 0
Restricted Cash	1,000,000		1,100,000
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents	29,500,000		27,500,000
Investments in rabbi trust	5,500,000		4,800,000
Derivative instruments	22,300,000		19,000,000
Liabilities:
Derivative instruments	28,100,000		40,500,000
Interest expense, net	25,100,000	29,800,000
Reported Value Measurement
Assets:
Receivables, Fair Value Disclosure	5,800,000		6,700,000
Liabilities:
Business Combination, Contingent Consideration, Liability	14,600,000		14,600,000
Schenck Process Food and Performance Materials
Liabilities:
Business Combination, Contingent Consideration, Liability						$ 14,600,000
$375 senior unsecured notes (2)
Liabilities:
Debt instrument, face amount									$ 350,000,000
Foreign Exchange Forward
Assets:
Derivative instruments	262,400,000		172,500,000
Cross Currency Interest Rate Contract
Assets:
Derivative instruments	691,900,000		727,800,000
Liabilities:
Interest expense, net	3,200,000	$ 0
Level 1
Assets:
Cash and cash equivalents	208,000,000		199,300,000
Receivables, Fair Value Disclosure	0		0
Restricted Cash	1,000,000		1,100,000
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents	29,500,000		27,500,000
Investments in rabbi trust	5,500,000		4,800,000
Derivative instruments	0		0
Liabilities:
Derivative instruments	0		0
Business Combination, Contingent Consideration, Liability	0		0
Level 2
Assets:
Cash and cash equivalents	0		0
Receivables, Fair Value Disclosure	5,800,000		6,700,000
Restricted Cash	0		0
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents	0		0
Investments in rabbi trust	0		0
Derivative instruments	22,300,000		19,000,000
Liabilities:
Derivative instruments	28,100,000		40,500,000
Business Combination, Contingent Consideration, Liability	0		0
Level 3
Assets:
Cash and cash equivalents	0		0
Receivables, Fair Value Disclosure	0		0
Restricted Cash	0		0
Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents	0		0
Investments in rabbi trust	0		0
Derivative instruments	0		0
Liabilities:
Derivative instruments	0		0
Business Combination, Contingent Consideration, Liability	14,600,000		14,600,000
$1,000 revolving credit facility (excluding outstanding letters of credit)
Liabilities:
Debt instruments	329,000,000		298,500,000
$1,000 revolving credit facility (excluding outstanding letters of credit) | 185 Euro Term Loan
Liabilities:
Long-Term Line of Credit | €								€ 185,000,000
$1,000 revolving credit facility (excluding outstanding letters of credit) | $200 term loan
Liabilities:
Long-Term Line of Credit							$ 200,000,000
$1,000 revolving credit facility (excluding outstanding letters of credit) | Level 1
Liabilities:
Debt instruments	0		0
$1,000 revolving credit facility (excluding outstanding letters of credit) | Level 2
Liabilities:
Debt instruments	329,000,000		298,500,000
$1,000 revolving credit facility (excluding outstanding letters of credit) | Level 3
Liabilities:
Debt instruments	0		0
$200 term loan
Liabilities:
Debt instruments	180,000,000		182,500,000
$200 term loan | Level 1
Liabilities:
Debt instruments	0		0
$200 term loan | Level 2
Liabilities:
Debt instruments	180,000,000		182,500,000
$200 term loan | Level 3
Liabilities:
Debt instruments	0		0
2021 Notes
Liabilities:
Debt instruments	350,000,000		350,000,000
2021 Notes | Level 1
Liabilities:
Debt instruments	306,200,000		312,900,000
2021 Notes | Level 2
Liabilities:
Debt instruments	0		0
2021 Notes | Level 3
Liabilities:
Debt instruments	0		0
2020 Notes
Liabilities:
Debt instruments	374,800,000		374,800,000
2020 Notes | Level 1
Liabilities:
Debt instruments	372,100,000		373,700,000
2020 Notes | Level 2
Liabilities:
Debt instruments	0		0
2020 Notes | Level 3
Liabilities:
Debt instruments	0		0
2019 Notes
Liabilities:
Debt instruments	500,000,000		500,000,000
2019 Notes | Level 1
Liabilities:
Debt instruments	501,400,000		509,800,000
2019 Notes | Level 2
Liabilities:
Debt instruments	0		0
2019 Notes | Level 3
Liabilities:
Debt instruments	0		0
One Hundred Ninety Five Million Euro Term Loan
Liabilities:
Debt instruments	180,900,000		196,500,000
One Hundred Ninety Five Million Euro Term Loan | Level 1
Liabilities:
Debt instruments	0		0
One Hundred Ninety Five Million Euro Term Loan | Level 2
Liabilities:
Debt instruments	180,900,000		196,500,000
One Hundred Ninety Five Million Euro Term Loan | Level 3
Liabilities:
Debt instruments	$ 0		$ 0
$400 senior unsecured notes (2) | 2019 Notes
Liabilities:
Debt instrument, face amount										$ 375,000,000
$400 senior unsecured notes (2) | Twenty Twenty Four Senior Unsecured Notes Due February Twenty Twenty Nine
Liabilities:
Debt instrument, face amount				$ 500,000,000

Segment and Geographical Info_3

Segment and Geographical Information - Schedule of net revenue and assets by segment (Details) $ in Millions	3 Months Ended
	Dec. 31, 2024 USD ($) segment	Dec. 31, 2023 USD ($)	Sep. 30, 2024 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment	2
Number of operating segments | segment	2
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	$ 706.9	$ 773.3
Total assets	5,059.4		$ 5,238.7
Property, plant, and equipment, net	461.5		485.3
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	284.7	326.9
Property, plant, and equipment, net	184.1		186.1
GERMANY
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	81.1	91.9
Property, plant, and equipment, net	123.5		134.5
CHINA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	57.1	57.9
Property, plant, and equipment, net	34.8		37.1
INDIA
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	51.1	59.1
Property, plant, and equipment, net	33.9		35.6
All other countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	232.9	237.5
Property, plant, and equipment, net	85.2		92
Corporate
Revenues from External Customers and Long-Lived Assets [Line Items]
Adjusted EBITDA (1)	(13.1)	(14)
Total assets	176.5		167.9
Advanced Process Solutions
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	511.1	568.3
Advanced Process Solutions | Operating segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Adjusted EBITDA (1)	82.8	96
Total assets	3,331.7		3,470.8
Milacron [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net revenue	195.8	205
Milacron [Member] | Operating segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Adjusted EBITDA (1)	27.4	$ 32.1
Total assets	$ 1,551.2		$ 1,600

Segment and Geographical Info_4

Segment and Geographical Information - Schedule of reconciliation of segment (Details 2) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Segment and Geographical Information
Loss from discontinued operations (net of income tax expense)	$ 0	$ (0.3)
Interest expense, net	25.1	29.8
Income tax expense	6.4	10
Depreciation and amortization	37.9	38.8
Pension settlement (gain) charge	(1.7)	8.3
Business acquisition, development, and integration costs	18.1	5.6
Inventory step-up costs	0	1.5
Inventory step-up	2.4	0.6
Income from continuing operations	8.9	19.2
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]
Segment and Geographical Information
Adjusted EBITDA (1)	(13.1)	(14)
Advanced Process Solutions | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	82.8	96
Milacron [Member] | Operating segments
Segment and Geographical Information
Adjusted EBITDA (1)	$ 27.4	$ 32.1

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event - Disposal Group, Held-for-Sale, Not Discontinued Operations - Milacron Injection Molding Business $ in Millions	Feb. 05, 2025 USD ($)
Subsequent Event [Line Items]
Percentage of business sold	51%
Ownership interest after disposal	49%
Business disposal, expected consideration	$ 287